Icosavax P/E Ratio

Icosavax (ICVX) currently reports a P/E ratio of -6.87. That is below the Healthcare sector average of 27.42. Use the charts on this page to explore Icosavax's P/E ratio history and peer comparisons.

Icosavax's P/E ratio of -6.87 is lower than the Healthcare sector average of 27.42. That is roughly 125.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Icosavax's market price to a fundamental measure such as earnings, sales, or book value. At -6.87, ICVX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -6.87, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.42. From there, open related valuation or income-statement pages for Icosavax, and consider following ICVX for alerts when major investors trade the stock.

Icosavax is classified in the Healthcare sector. On P/E ratio, it currently shows -6.87 versus a sector average near 27.42. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ICVX with unrelated industries.